Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-27 @ 4:14 AM
Study NCT ID:
NCT03173092
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-28
First Post:
2017-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-30
First Submit QC Date:
None
Study First Post Date:
2017-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-27
Last Update Post Date:
2025-03-28
Last Update Post Date Type:
ACTUAL